‘Close The R&D Gap’ Between EU & Other Regions, EFPIA Tells Lawmakers
As EU legislators begin their discussion of the EU pharmaceutical overhaul, EFPIA has issued its formal response to the proposals, with a focus on topics such as unmet medical need, environmental risk assessments and drug shortages.
